154 related articles for article (PubMed ID: 32298379)
1. Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomas.
Karstens KF; Kempski J; Giannou AD; Freiwald E; Reeh M; Tachezy M; Izbicki JR; Lohse AW; Gagliani N; Huber S; Pelczar P
PLoS One; 2020; 15(4):e0231833. PubMed ID: 32298379
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival.
Karstens KF; Kempski J; Giannou AD; Pelczar P; Steglich B; Steurer S; Freiwald E; Woestemeier A; Konczalla L; Tachezy M; Reeh M; Bockhorn M; Perez D; Mann O; Lohse AW; Roesch T; Izbicki JR; Gagliani N; Huber S
Cancer Immunol Immunother; 2020 Jun; 69(6):1043-1056. PubMed ID: 32100077
[TBL] [Abstract][Full Text] [Related]
3. Cytokine profiles in patients with newly diagnosed multiple myeloma: Survival is associated with IL-6 and IL-17A levels.
Gu J; Huang X; Zhang Y; Bao C; Zhou Z; Jin J
Cytokine; 2021 Feb; 138():155358. PubMed ID: 33183958
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-17A modulates circulating tumor cells in tumor draining vein of colorectal cancers and affects metastases.
Tseng JY; Yang CY; Liang SC; Liu RS; Yang SH; Lin JK; Chen YM; Wu YC; Jiang JK; Lin CH
Clin Cancer Res; 2014 Jun; 20(11):2885-97. PubMed ID: 24677375
[TBL] [Abstract][Full Text] [Related]
5. Analysis of pro- and anti-inflammatory cytokine gene variants and serum cytokine levels as prognostic markers in breast cancer.
Kaur RP; Vasudeva K; Singla H; Benipal RPS; Khetarpal P; Munshi A
J Cell Physiol; 2018 Dec; 233(12):9716-9723. PubMed ID: 30078181
[TBL] [Abstract][Full Text] [Related]
6. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17A promotes esophageal adenocarcinoma cell invasiveness through ROS-dependent, NF-κB-mediated MMP-2/9 activation.
Liu D; Zhang R; Wu J; Pu Y; Yin X; Cheng Y; Wu J; Feng C; Luo Y; Zhang J
Oncol Rep; 2017 Mar; 37(3):1779-1785. PubMed ID: 28184939
[TBL] [Abstract][Full Text] [Related]
8. Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences.
Gockel I; Kneist W; Junginger T
World J Surg; 2006 Feb; 30(2):183-90. PubMed ID: 16425075
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 and -12 predict chemotherapy-associated toxicity in esophageal adenocarcinoma.
Schauer MC; Holzmann B; Peiper M; Friess H; Knoefel WT; Theisen J
J Thorac Oncol; 2010 Nov; 5(11):1849-54. PubMed ID: 20881642
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of IgG4+ plasma cell infiltrates following neoadjuvant chemoradiation therapy for esophageal adenocarcinoma.
Yakirevich E; Lu S; Allen D; Mangray S; Fanion JR; Lombardo KA; Safran H; Resnick MB
Hum Pathol; 2017 Aug; 66():126-135. PubMed ID: 28666927
[TBL] [Abstract][Full Text] [Related]
11. IL-17A Levels in the Sera of Patients with Gastric Cancer Show Limited Elevation.
Malek-Hosseini Z; Taherinejad M; Malekzadeh M; Ghaderi A; Doroudchi M
Asian Pac J Cancer Prev; 2015; 16(16):7149-53. PubMed ID: 26514504
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
Dunne MR; Michielsen AJ; O'Sullivan KE; Cathcart MC; Feighery R; Doyle B; Watson JA; O'Farrell NJ; Ravi N; Kay E; Reynolds JV; Ryan EJ; O'Sullivan J
Cancer Immunol Immunother; 2017 Jul; 66(7):841-850. PubMed ID: 28315927
[TBL] [Abstract][Full Text] [Related]
13. High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer.
Silva EM; Mariano VS; Pastrez PRA; Pinto MC; Castro AG; Syrjanen KJ; Longatto-Filho A
PLoS One; 2017; 12(7):e0181125. PubMed ID: 28715437
[TBL] [Abstract][Full Text] [Related]
14. Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study.
Thein HH; Anyiwe K; Jembere N; Yu B; De P; Earle CC
PLoS One; 2017; 12(10):e0186350. PubMed ID: 29020052
[TBL] [Abstract][Full Text] [Related]
15. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
[TBL] [Abstract][Full Text] [Related]
16. An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β.
Balasa R; Maier S; Voidazan S; Hutanu A; Bajko Z; Motataianu A
CNS Neurol Disord Drug Targets; 2015; 14(6):804-10. PubMed ID: 25801840
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma.
Kato S; Okamura R; Baumgartner JM; Patel H; Leichman L; Kelly K; Sicklick JK; Fanta PT; Lippman SM; Kurzrock R
Clin Cancer Res; 2018 Dec; 24(24):6248-6256. PubMed ID: 30348637
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of IL-17A in patients with fibromyalgia.
Pernambuco AP; Schetino LP; Alvim CC; Murad CM; Viana RS; Carvalho LS; Reis DÁ
Clin Exp Rheumatol; 2013; 31(6 Suppl 79):S60-3. PubMed ID: 24021410
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma.
Doroudchi M; Pishe ZG; Malekzadeh M; Golmoghaddam H; Taghipour M; Ghaderi A
Asian Pac J Cancer Prev; 2013; 14(9):5225-30. PubMed ID: 24175805
[TBL] [Abstract][Full Text] [Related]
20. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
Zhang L; Cheng Z; Liu W; Wu K
COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
